Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt IssuancesLong-Term Debt RepaymentsReceivables - AccuredReceivables - OtherRevenue (Gross)Shares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

PhenixFIN (PFX) Receivables - Accured (2022 - 2026)

PhenixFIN has reported Revenue - Other over the past 5 years, most recently at $200000.0 for Q4 2025.

  • Quarterly Revenue - Other rose 174.82% to $200000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $297774.0 through Dec 2025, up 309.18% year-over-year, with the annual reading at $700000.0 for FY2025, 3181718.18% up from the prior year.
  • Receivables - Accured was $1.0 million for Q4 2025 at PhenixFIN, down from $1.2 million in the prior quarter.
  • Over five years, Receivables - Accured peaked at $1.7 million in Q2 2024 and troughed at $725649.0 in Q1 2023.
  • The 4-year median for Receivables - Accured is $1.1 million (2025), against an average of $1.2 million.
  • Year-over-year, Revenue - Other soared 330690.91% in 2024 and then soared 174.82% in 2025.
  • A 5-year view of Revenue - Other shows it stood at $230434.0 in 2021, then plummeted by 59.47% to $93394.0 in 2022, then plummeted by 99.98% to $22.0 in 2023, then soared by 330690.91% to $72774.0 in 2024, then soared by 174.82% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for PFX's Revenue - Other are $200000.0 (Q4 2025), $25000.0 (Q1 2025), and $72774.0 (Q4 2024).